Advanced generation adenoviral virotherapy agents embody enhanced potency based upon CAR-independent tropism
- PMID: 16675555
- PMCID: PMC2203211
- DOI: 10.1158/1078-0432.CCR-06-0497
Advanced generation adenoviral virotherapy agents embody enhanced potency based upon CAR-independent tropism
Figures
Comment on
-
Enhanced gene transfer and oncolysis of head and neck cancer and melanoma cells by fiber chimeric oncolytic adenoviruses.Clin Cancer Res. 2006 May 1;12(9):2869-78. doi: 10.1158/1078-0432.CCR-05-2397. Clin Cancer Res. 2006. PMID: 16675583
References
-
- Reddy PS, Ganesh S, Yu D-C. Enhanced gene transfer and oncolysis of head and neck cancer and melanoma cells by fiber chimeric oncolytic adenoviruses. Clin Cancer Res. 2006;12:2869–78. - PubMed
-
- Sinkovics J, Horvath J. New developments in the virus therapy of cancer: a historical review. Intervirology. 1993;36:193–214. - PubMed
-
- Khuri FR, Jain SR. Novel agents and incremental advances in the treatment of head and neck cancer. Semin Oncol. 2004;31:3–10. - PubMed
-
- Fueyo J, Gomez-Manzano C, Alemany R, et al. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene. 2000;19:2–12. - PubMed
-
- Kanerva A, Bauerschmitz GJ, Yamamoto M, et al. A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinoma. Gene Ther. 2004;11:552–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
